A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2011
12/07/2011	EP2392354A1 Finely pulverized pharmaceutical composition
12/07/2011	EP2392323A1 Prostate cancer progression inhibitor and progression inhibition method
12/07/2011	EP2392321A1 Combined composition for rectal administration for the treatment of inflammatory bowel disease
12/07/2011	EP2392320A1 Treatment of inflammatory diseases
12/07/2011	EP2391369A1 Delayed-release glucocorticoid treatment of asthma
12/07/2011	EP2391359A1 Dpp-iv inhibitors for treatment of diabetes in paediatric patients
12/07/2011	EP2391211A1 Methods and compositions for treating breast cancer
12/07/2011	EP2391209A1 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes
12/07/2011	EP1420851B1 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas
12/07/2011	EP1294770B1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
12/07/2011	CN102271711A 每种维持移植物抗肿瘤效应的免疫重建促进剂或感染预防剂 Each maintaining graft-versus-tumor effect of immune reconstitution accelerator or infection prevention agent
12/07/2011	CN102271689A 氦-氧气体混合物用于治疗肺动脉高压的用途 Helium - oxygen mixture for the treatment of pulmonary arterial hypertension
12/07/2011	CN102271673A 尽管接受包括dpp-iv抑制剂的二甲双胍治疗但血糖控制仍不足的患者中的糖尿病的治疗 Including treatment of patients despite receiving metformin dpp-iv inhibitor but still insufficient glycemic control in diabetes
12/07/2011	CN102269766A 人类基因fam96a及其蛋白质的应用 Human genes and proteins applications fam96a
12/07/2011	CN102266569A miR-199a及其抑制剂的应用 Application of miR-199a and its inhibitors
12/07/2011	CN102266563A 一种复方止痛组合物及其制备方法 A COMPOUND analgesic composition and preparation method
12/07/2011	CN102266562A 一种用于治疗病毒性肝炎的药物组合物 A pharmaceutical composition for the treatment of viral hepatitis
12/07/2011	CN102266561A Wnt/β-catenin信号通路抑制剂在制备促进细胞凋亡的药物中的应用 Wnt / β-catenin signaling pathway inhibitors in the manufacture of a medicament in promoting apoptosis
12/07/2011	CN102266560A 一种用于治疗气喘的药物组合物 A pharmaceutical composition for the treatment of asthma for
12/07/2011	CN102266559A 包含替米沙坦盐和钙离子拮抗剂的药物组合物 Containing salts and calcium antagonist telmisartan pharmaceutical composition
12/07/2011	CN102266558A 抗骨桥蛋白单克隆抗体对骨质疏松的保护作用 Anti-osteopontin monoclonal antibody against osteoporosis
12/07/2011	CN102266302A 旨在避免非主观误服和非法滥服的抗张性片剂 Designed to avoid the reach of non-subjective and illegal Lanfu tensile tablets
12/07/2011	CN101780281B N-精氨酸壳聚糖作为透皮吸收促进剂的应用 N- arginine chitosan as an application of penetration enhancers
12/07/2011	CN101670116B 一种共轭亚油酸与抗肿瘤药物连接的前体药物及其制备方法 A prodrug conjugate linoleic acid and its preparation method connected with anticancer drugs
12/07/2011	CN101189044B 包含一种抗真菌剂以及一种选自丁香酚、麝香草酚和香芹酚的活性物质的药物组合物 Contains an antifungal agent and one member selected from eugenol, thymol and carvacrol of active substance pharmaceutical composition
12/07/2011	CN101121021B 人源化抗ErbB2抗体及用抗ErbB2抗体进行的治疗 Humanized anti-ErbB2 antibody treatment with anti-ErbB2 antibody and carried out
12/07/2011	CN101102795B 用于抑制纤维化的药物载体和药物载体试剂盒 Drug carrier for inhibiting fibrosis and drug carrier kit
12/06/2011	US8071777 Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine
12/06/2011	US8071729 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071578 Tazarotene and corticosteroid treatment for psoriasis
12/06/2011	US8071576 Fewer side effects; usable for longer period of time; lower recurrence rates after discontinuation; combination of progestogen and androgen components; kits
12/06/2011	US8071571 Orlistat compositions
12/06/2011	US8071567 4′-substituted nucleoside derivatives as inhibitors of HCV RNA replication
12/06/2011	US8071356 Salmonella enterica strains of reduced pathogenicity, method for their preparation and uses thereof
12/06/2011	US8071333 Anti-integrin antibodies, compositions, methods and uses
12/06/2011	US8071294 Cancer therapy sensitizer
12/06/2011	US8071120 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
12/06/2011	US8071075 Physiologically active agent, octyl dimethyl-para-aminobenzoate, volatile liquid; applying a hormone by aerosol
12/06/2011	US8071074 e.g. (6,7-(dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine; epidermal growth factor receptor (EGF-R) antagonist, tyrosine kinase inhibitor; hypersecretion of mucus in lungs: chronic bronchitis, acute asthma, cystic fibrosis, bronchiectasis, chronic obstructive lung disease
12/06/2011	CA2541813C Methods for treating acute and overuse sprain and strain using hyaluronic acid
12/06/2011	CA2491243C Viral inhibitors
12/06/2011	CA2486759C Universal chimera bank
12/06/2011	CA2485351C Cyanoguanidine prodrugs
12/06/2011	CA2455620C Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/06/2011	CA2449520C Swallow tablet comprising paracetamol
12/06/2011	CA2448482C Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
12/06/2011	CA2393464C An additive for an animal feed
12/06/2011	CA2383522C Neurotherapeutic composition and method
12/06/2011	CA2380858C Inhibitors of aspartyl protease
12/06/2011	CA2370867C Use of glucose-6-phosphate isomerase and antibodies thereto for the diagnosis and therapy of arthritis, and test of anti-arthritic compounds
12/06/2011	CA2309954C Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
12/06/2011	CA2211039C Medicinal combination useful for in vivo exogenic transfection and expression
12/06/2011	CA2202087C Cloning and characterizing of genes associated with long-term memory
12/01/2011	WO2011150240A1 Nanocarrier compositions with uncoupled adjuvant
12/01/2011	WO2011149824A1 Cancer therapy using a combination of a hsp90 inhibitory compound and a topoisomerase ii inhibitor
12/01/2011	WO2011149337A1 New combination treatment for type 2 diabetes and other disorders related to insulin resistance
12/01/2011	WO2011149096A1 Insulin-resistance-improving drug
12/01/2011	WO2011149046A1 Therapeutic agent for pancreatic cancer
12/01/2011	WO2011148405A1 Compositions for treating helicobacter pylori infection
12/01/2011	WO2011147528A1 Biguanide compounds and its use for treating cancer
12/01/2011	WO2011126352A3 Anti-tuberculosis preparation based on an inclusion complex of cyclodextrin with rifampicin and a method for the preparation thereof
12/01/2011	WO2011120930A8 Method for stimulating the reproductive capacity in a bull, and composition for stimulating the reproductive capacity in a bull
12/01/2011	WO2011104161A9 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field
12/01/2011	WO2011076843A3 Combination therapy for copd
12/01/2011	US20110294881 METHODS FOR TREATING LOWER URINARY TRACT DISORDERS USING alpha2delta SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS
12/01/2011	US20110294821 5-ht1a receptor subtype agonist
12/01/2011	US20110293588 Metabolic uncoupling therapy
11/2011
11/30/2011	EP2389953A1 Method of inhibiting receptor tyrosine kinases with an extracellular antagonist and an intracellular antagonist
11/30/2011	EP2389943A1 Use of IL-174 antagonists for treating Th2-related diseases
11/30/2011	EP2389937A1 Medicinal composition for improving brain function
11/30/2011	EP2389197A1 Combinations comprising methotrexate and dhodh inhibitors
11/30/2011	EP2389196A1 Phd2 inhibition for blood vessel normalization, and uses thereof
11/30/2011	EP2389187A1 Sorbic and benzoic acid and derivatives thereof enhance the activity of a neuropharmaceutical
11/30/2011	EP2389186A2 A phytochemical composition and a process thereof
11/30/2011	EP2389173A1 New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative
11/30/2011	EP2156833B1 Prophylactic or therapeutic agent for posterior ocular disease comprising non-ergot selective d2 receptor agonist as active ingredient
11/30/2011	EP2040707B1 Combination of atorvastatin with a phosphodiesterase 4 inhibitor for the treatment of inflammatory pulmonary diseases
11/30/2011	EP1904108B1 Ophthalmological formulation comprising methylsulfonylmethane and ciprofloxacin
11/30/2011	EP1702626B1 Screening method for gamma-secretase inhibitors
11/30/2011	CN202051386U 脑梗塞后遗症康复用药枕 Sequelae of cerebral infarction rehabilitation therapy pillow
11/30/2011	CN1656222B 反义iap核碱基寡聚物及其应用 Iap nucleobase antisense oligomer and its application
11/30/2011	CN102264891A Th2细胞诱导用组合物和Th2型疾病的治疗组合物、以及该组合物的利用 Th2 cells induce therapeutic composition compositions and Th2-type diseases, as well as the composition of use
11/30/2011	CN102258784A 用于预防和治疗败血症的方法与组合物 For the prevention and treatment of sepsis methods and compositions
11/30/2011	CN102258783A Gsk3抑制剂在制备治疗高雄激素血症药物中的用途 Gsk3 inhibitor in the preparation of a medicament for the treatment of hyperandrogenism uses
11/30/2011	CN102258782A 肾上腺素受体阻断药在拮抗水母毒素心脏毒性中的应用 Adrenergic receptor blocking drugs used in antagonizing the cardiac toxicity jellyfish toxin
11/30/2011	CN102258477A 一种抗移植免疫排斥反应的新型j2-海藻酸钠微球缓释免疫抑制剂、制备方法和用途 An anti-graft immune rejection of the new j2- alginate microspheres sustained release immunosuppressants, preparation and use
11/30/2011	CN102258464A 高浓度抗体和蛋白制剂 High concentrations of antibody and protein formulations
11/30/2011	CN102258458A 一种用于退热的直肠用原位凝胶剂及其制备方法 Rectal gel in situ method for its preparation antipyretic
11/30/2011	CN102258457A Non-aqueous composition
11/30/2011	CN101632663B 神经毒性的分子靶 Molecular targets neurotoxicity
11/29/2011	US8068580 Methods and devices for quantitative analysis of x-ray images
11/29/2011	US8067444 Administering to a diabetic patient with a baseline serum creatinine concentration of =/>1.3 mg/dL an amount of pyridoxamine or its chloride to limit renal disease progression and/or diabetic complications to slow the increase in serum creatinine levels in the patient relative to placebo; ACE inhibitors
11/29/2011	US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011	US8067385 Antiviral oligonucleotides targeting HBV
11/29/2011	US8067367 Methods of increasing platelet and hematopoietic stem cell production
11/29/2011	US8067240 Methods for the diagnosis and treatment of lung cancer
11/29/2011	US8067229 Ucp4
11/29/2011	US8067221 Von Willebrand factor (vWF)-cleaving protease
11/29/2011	US8067219 Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide
11/29/2011	US8067203 Composition for treating porcine progressive atrophic rhinitis and making process thereof

1 ... 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 ... 1151